BillionToOne

Exciting things to come with Premji Invest - US! Your investment and partnership will help us continue to transform the diagnostics landscape. Thank you!

BillionToOne continues to be highlighted in NYC! Thank you to NYSE for showcasing our Series D announcement! #NYSE #BillionToOne #SeriesD #PremjiInvest #prenatal #oncology #UNITY #Northstar

A huge thank you to Nasdaq for highlighting BillionToOne on the Times Square tower today! 💥 $130 million in an oversubscribed, upsized Series D funding 🌟 Over $1B+ Valuation 🚀 $0M to $125M ARR in the last ~4 years 🩺 The future of healthcare is here! #BillionToOne #UNITYComplete #Northstar #prenatalhealth #oncology #Nasdaq #SeriesD

Today we announced the successful completion of a Series D funding round, raising $130 million and bringing our total valuation to over $1B. The round was led by Premji Invest and Neuberger Berman, with participation from our existing investors. The funds will be allocated to further scale our prenatal screening and oncology diagnostics businesses, expanding the reach of our innovative tests powered by our proprietary Quantitative Counting Templates (QCTs) technology. Over 500,000 patients have benefited from our cutting-edge tests to date. We appreciate the support of our investors and the dedication of our team as we work towards our mission to make molecular diagnostics more powerful, efficient, and accessible for all. Read our press release here ➡ https://lnkd.in/gj5fF9hH Claire Rychlewski from Axios wrote about the news here ➡ https://lnkd.in/gd-FeKhh #oncology #prenatalhealth #moleculardiagnostics #BillionToOne #UNITY #Northstar #Axios

🏆 We are excited to announce that our very own CEO, Oguzhan Atay, PhD has been recognized by Slice of Healthcare as a Top Leader in Digital Health! A huge congrats to Oguzhan and the other honorees! View the list here ➡ https://lnkd.in/eh5cuuEr #SoHCTopDigitalHealthLeaders #BillionToOne

Happy Father's Day to all of the men who show up for us, support us and love us 💙

UNITY Complete will be at the Julian Wells Lectureship in Dallas today! Learn about our groundbreaking first-of-its-kind testing for fetal RhD. We look forward to meeting you! #RhD #UNITYComplete #prenatalhealth

Thank you Clinical Trials Arena for highlighting Northstar Select and Dr. Gary Palmer! "Patients with low levels of ctDNA could benefit most from BillionToOne’s NorthStar Select. BillionToOne analyzed clinical samples from 182 patients with advanced forms of solid tumors using its NorthStar Select or comparator assays. The company found its assay detected 46% more SNVs/Indels and of those, 69% were clinically actionable. “The great majority of variants that we found that the other assays did not were in the low variant allele fraction, the very low range. This more sensitive test could find things that other assays could not,” BillionToOne’s Chief Medical Officer Dr Gary Palmer told Medical Device Network. " Read more here ➡  https://lnkd.in/erRCV4u7 #NorthstarSelect #Oncology #ClinicalTrials

Want to learn more about UNITY Complete and explore how our innovative solutions can benefit your practice? Meet us today in Philadelphia at, The 16th Philadelphia Prenatal Diagnosis, Genetics, Ultrasound, Obstetrics & MFM Hybrid Conference! #prenatalhealth #UNITYComplete

Last Day to Connect! As we wrap up an incredible experience here at ASCO, we want to remind you of two must-see opportunities for advancing patient care. Visit us at booth #16024 or check out posters #3072 and #2077 to explore the transformative potential of our complementary liquid biopsy assays. These innovative assays are designed to expand treatment options and enable more precise monitoring of your patient's treatment response, paving the way for personalized and effective oncology care. Don't miss the chance to connect with our team and dive deeper into these groundbreaking advancements. We’re here to answer your questions and collaborate on shaping the future of cancer treatment. Let’s push the boundaries of what’s possible—together 🚀 #ASCO2024 #Oncology #LiquidBiopsy #PatientCare #HealthcareInnovation